Acter (5536) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
10 Jun, 2026Executive summary
Achieved record consolidated revenue of NT$30.25 billion in 2024, with EPS reaching a historical high of NT$21.09 (par value NT$5).
Maintained a high backlog exceeding NT$38 billion, supporting future operations.
Business is diversified across Taiwan, China, and Southeast Asia, with a strong focus on cleanroom electromechanical and semiconductor industries.
Gross profit margin improved to 24% in 2024 from 19% in 2023.
The audit opinion was unqualified, with revenue recognition highlighted as a key audit matter due to estimation uncertainty in construction contracts.
Financial highlights
Operating revenue grew 21% year-over-year to NT$30.25 billion in 2024.
Gross profit margin increased to 21% from 20% year-over-year; gross profit up 34%.
Operating income rose 35% to NT$4.41 billion; profit after tax attributable to parent up 42%.
ROE improved to 24.07% in 2024 from 21.76% in 2023.
Positive operating cash flow, with cash and cash equivalents rising to NT$9.9 billion at mid-2024.
Outlook and guidance
High backlog of NT$38 billion ensures robust revenue visibility for upcoming periods.
The company expects to recognize NT$16,069 million in remaining construction contract revenue over the next 1–3 years.
Cleanroom and semiconductor markets expected to grow, driven by demand in Asia Pacific and China.
Focus on leveraging AI, decentralized production, and green engineering for future growth.
Latest events from Acter
- Q1 2024 delivered strong margins, record backlog, robust cash, and a qualified audit review.5536
Q1 202410 Jun 2026 - Record-high revenue and EPS, strong backlog, and improved gross margin at 22%.5536
Q3 202410 Jun 2026 - Record 2024H1 EPS, strong backlog, and top ESG/ROE metrics, with a qualified auditor review.5536
Q2 202410 Jun 2026 - Q1 2025 revenue rose 56% with strong net income and backlog, but audit and cash flow risks remain.5536
Q1 202510 Jun 2026 - Record revenue and EPS in 2025H1, with strong backlog and some credit risk concentration.5536
Q2 202510 Jun 2026 - Record revenue and EPS in 2025 Q1–Q3, with strong backlog and ongoing legal and credit risks.5536
Q3 202510 Jun 2026 - Record revenue, high backlog, and strong EPS growth driven by semiconductor and cleanroom projects.5536
Q1 202610 Jun 2026 - Record revenue, strong backlog, and high ROE drive growth and sustained high dividends.5536
Q4 202510 Jun 2026